A new derivatization reagent for LC-MS/MS screening of potential genotoxic alkylation compounds. 2013

A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
Abbott Healthcare Products BV, Manufacturing, Science and Technology, Established Pharmaceuticals, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands.

A screening method for trace analysis of potentially genotoxic alkylating compounds has been developed using butyl 1-(pyridin-4-yl) piperidine 4-carboxylate (BPPC) as a new, selective pre-column derivatization reagent for their subsequent analysis by hydrophilic interaction liquid chromatography (HILIC) hyphenated with tandem mass spectrometry (LC-MS/MS). The new derivatization reagent is a modification of 4-dimethylaminopyridine (4-DMAP) previously used for the determination of potentially genotoxic compounds. By using the new reagent the screening potential was enhanced without compromising reactivity. Derivatization at a high pH value was carried out and the reaction time at 60°C was 24h to anticipate for alkyl chlorides showing to be less reactive. The new reagent was designed to obtain reagent related fragmentation of the whole reagent as well as a side group of the reagent. Collision energies for detection of alkylating components derivatized using the new reagent are shown to be significantly more universal than with 4-DMAP. Neutral loss scanning on the fragmentation related to the build in side group remedies shortcomings in the screening for alkyl halides observed when using 4-DMAP. The new approach allows for screening of alkyl halides and alkyl sulfonates at trace levels down to 1 mg kg(-1) and target analysis at about a factor of 10 lower without a significant effect of the active pharmaceutical ingredient (API) matrix. The synthesis of the reagent, investigation of reactivity, the specificity of the fragmentation of derivatives and screening conditions in MS/MS analysis are described.

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000478 Alkylation The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. Alkylations
D015761 4-Aminopyridine One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes. 4-Aminopyridine Sustained Release,Dalfampridine,Fampridine-SR,Pymadine,VMI-103,4 Aminopyridine,4 Aminopyridine Sustained Release,Fampridine SR,Sustained Release, 4-Aminopyridine,VMI 103,VMI103
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem

Related Publications

A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
September 2012, Journal of chromatography. A,
A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
January 2023, Talanta,
A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
August 2023, Journal of lipid research,
A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
October 2015, Bioanalysis,
A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
April 2017, Journal of lipid research,
A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
September 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
August 2021, Talanta,
A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
September 2006, Journal of pharmaceutical and biomedical analysis,
A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
November 2012, Analytical chemistry,
A M van Wijk, and H A G Niederländer, and A H G Siebum, and M A T Vervaart, and G J de Jong
January 2017, Chromatographia,
Copied contents to your clipboard!